[Clinical experience in benzodiazepine antagonist]

Area of Science:

• Pharmacology
• Clinical Toxicology

Background:

• Benzodiazepines are commonly prescribed sedatives/hypnotics.
• Overdose can lead to significant central nervous system depression and coma.
• Effective antidotes are crucial for managing overdose and aiding diagnosis.

Observation:

• Fifteen comatose patients with suspected sedative/hypnotic overdose received intravenous flumazenil.
• The average Glasgow Coma Scale score increased from 7.13 to 10.93 after initial flumazenil administration.
• Full consciousness was restored in some patients following multiple flumazenil doses.

Findings:

• Flumazenil administration significantly improved neurological function in overdose patients.
• The study demonstrated flumazenil's efficacy as a benzodiazepine antagonist.
• Dosages ranged from 0.25 mg to 3 mg, with an average of 0.87 mg.

Implications:

• Flumazenil is a highly effective antidote for benzodiazepine overdose.
• It serves as a valuable diagnostic tool to differentiate causes of coma in overdose patients.
• This research supports the clinical utility of flumazenil in emergency toxicology settings.